| Gene symbol | CD19 | Synonyms | B4, CVID3 | Type of gene | protein-coding | |
| Chromosome | 16 | Map location | 16p11.2 | dbXrefs | Entrez:930 MIM:107265 HGNC:HGNC:1633 Ensembl:ENSG00000177455 AllianceGenome:HGNC:1633 | |
| Description | CD19 molecule | |||||
| GTO ID | GTC1011 |
| Trial ID | ChiCTR2200063517 |
| Disease | B-Cell Non-Hodgkin's Lymphoma |
| Altered gene | CD19 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | CD19 CAR-T cells |
| Phase | Early_Phase1 |
| Recruitment status | Not Recruiting |
| Title | Phase I Trial of Anti-CD 19 Universal CAR-T Therapy For Relapsed/Refractory B-cell Non-Hodgkin Lymphoma |
| Year | 2022 |
| Country | China |
| Company sponsor | Shaanxi Provincial People's Hispital |
| Cohort 1 | |||||||||
|
|||||||||